- Home
- INBK vs PRQR Comparison
INBK vs PRQR Comparison
Compare INBK & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INBK
- PRQR
- Stock Information
- Founded
- INBK 1999
- PRQR 2012
- Country
- INBK United States
- PRQR Netherlands
- Employees
- INBK N/A
- PRQR 166
- Industry
- INBK Major Banks
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- INBK Finance
- PRQR Health Care
- Exchange
- INBK Nasdaq
- PRQR Nasdaq
- Market Cap
- INBK 196.2M
- PRQR 244.4M
- IPO Year
- INBK N/A
- PRQR 2014
- Fundamental
- Price
- INBK $27.50
- PRQR $2.26
- Analyst Decision
- INBK Buy
- PRQR Strong Buy
- Analyst Count
- INBK 4
- PRQR 8
- Target Price
- INBK $34.50
- PRQR $8.88
- AVG Volume (30 Days)
- INBK 61.2K
- PRQR 342.1K
- Earning Date
- INBK 07-23-2025
- PRQR 08-07-2025
- Dividend Yield
- INBK 0.87%
- PRQR N/A
- EPS Growth
- INBK 27.37
- PRQR N/A
- EPS
- INBK 2.40
- PRQR N/A
- Revenue
- INBK $114,609,000.00
- PRQR $21,212,711.00
- Revenue This Year
- INBK $6.41
- PRQR N/A
- Revenue Next Year
- INBK $17.52
- PRQR N/A
- P/E Ratio
- INBK $11.55
- PRQR N/A
- Revenue Growth
- INBK 20.13
- PRQR 85.91
- 52 Week Low
- INBK $19.54
- PRQR $1.07
- 52 Week High
- INBK $43.27
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- INBK 59.23
- PRQR 56.82
- Support Level
- INBK $26.82
- PRQR $2.27
- Resistance Level
- INBK $28.15
- PRQR $2.51
- Average True Range (ATR)
- INBK 0.76
- PRQR 0.13
- MACD
- INBK -0.08
- PRQR -0.00
- Stochastic Oscillator
- INBK 46.28
- PRQR 51.49
About INBK First Internet Bancorp
First Internet Bancorp is a bank holding company. Through its subsidiaries, it provides commercial real estate (CRE) lending, including nationwide single tenant lease financing and commercial and industrial (C&I) lending, including business banking or treasury management services. The company offers its products and services through the internet and does not have any branches. With operations organized into a single segment called the Commercial Banking segment, it also provides retail banking services.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.